Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Oct 20 - Oct 25
Image credit: KaterynaBorodina/Shutterstock.com In a recent study published in the International Journal of Obesity , a group of researchers examined whether people experience stigma after losing or regaining weight following the use and discontinuation of glucagon-like peptide-1 receptor agonist (GLP-1RAs) medications
Methods Study data The population-based cohort study was done by the linkage of several national Swedish registries
It is intended to be used along with a reduced-calorie diet and exercise to assist people with a body mass index (BMI) 30 kg/m 2 or 27 kg/m 2 with at least one weight-related medical condition, such as high blood pressure
In combination with a healthy diet and exercise
US$ 20.14
US$ 24.50
US$ 26.44
US$ 24.90
US$ 23.39
